{"archive_url":"https://www.ebi.ac.uk/ega/datasets/EGAD00001002400","experiment":{"EXPERIMENT_TYPE":"Histone H3K27ac","EXPERIMENT_ID":"EGAX00001365839","attributes":{"EXTRACTION_PROTOCOL_SONICATION_CYCLES":["\"7 min; 30 sec ON/ 30 sec OFF\""],"CHIP_ANTIBODY":["H3K27ac"],"CHIP_PROTOCOL_BEAD_TYPE":["magnetic beads A"],"CHIP_PROTOCOL_BEAD_AMOUNT":["20 ul"],"EXPERIMENT_TYPE":["Histone H3K27ac"],"CHIP_ANTIBODY_CATALOG":["BP grade"],"CHIP_ANTIBODY_LOT":["A1723-0041d"],"CHIP_PROTOCOL_ANTIBODY_AMOUNT":["1,0 ug"],"CHIP_PROTOCOL_CHROMATIN_AMOUNT":["1x 500.000 cells = 33 ul"],"EXTRACTION_PROTOCOL":["Chromatin was extracted using the histone protocol. Cells are crosslinked 10 min in 1% formaldehyde. Washed twice in PBS and dissolved in shearing buffer (containing 1% SDS), such that the final concentration is 15*10^6 cells/ml."],"CHIP_PROTOCOL":["Protocol July 2014: 500.000 cells per ChIP. Overnight incubation of chromatin with antibody. 1 hour incubation in the morning with A/G magnetic beads. Wash once with buffer 1, and twice with buffer 2 and 3 at 4 degrees. Elute 20 min with elution buffer at RT. Descrosslink 4 hours at 65 degrees. Purify by column purification."],"CHIP_ANTIBODY_PROVIDER":["Diagenode"],"LIBRARY_GENERATION_FRAGMENT_SIZE_RANGE":["214"],"EXTRACTION_PROTOCOL_TYPE_OF_SONICATOR":["Bioruptor Pico (UCD-600)"]},"ASSAY_TYPE":"ChIP-Seq"},"archive":"EGA","ftp_path":"http://ftp.ebi.ac.uk/pub/databases/blueprint/data/homo_sapiens/GRCh38/capillary_blood/T12C/T-cell_Acute_Lymphocytic_Leukemia/ChIP-Seq/NCMLS","files":[{"FORMAT":"bigWig","SIZE":"700M","NAME":"S01PX4H1.ERX1305349.H3K27ac.bwa.GRCh38.20160226.bw","FILE_TYPE":"CHIP_WIGGLER","ANALYSIS_GROUP":"EMBL-EBI","TYPE":"Normalized signal","PATH":"http://ftp.ebi.ac.uk/pub/databases/blueprint/data/homo_sapiens/GRCh38/capillary_blood/T12C/T-cell_Acute_Lymphocytic_Leukemia/ChIP-Seq/NCMLS/S01PX4H1.ERX1305349.H3K27ac.bwa.GRCh38.20160226.bw","PROTOCOL_DOC":"chip_seq_grch38","MD5":"bb7c7e2f385afdad2a05dbf6f6210078"},{"FORMAT":"bigBed","SIZE":"423K","NAME":"S01PX4H1.ERX1305349.H3K27ac.bwa.GRCh38.20160310.bb","FILE_TYPE":"CHIP_MACS2_BB","ANALYSIS_GROUP":"EMBL-EBI","TYPE":"Enriched regions","PATH":"http://ftp.ebi.ac.uk/pub/databases/blueprint/data/homo_sapiens/GRCh38/capillary_blood/T12C/T-cell_Acute_Lymphocytic_Leukemia/ChIP-Seq/NCMLS/S01PX4H1.ERX1305349.H3K27ac.bwa.GRCh38.20160310.bb","PROTOCOL_DOC":"chip_seq_grch38","MD5":"ff89a36dce5c3c1b81ea0b90389c141d"},{"FORMAT":"BED","SIZE":"463K","NAME":"S01PX4H1.ERX1305349.H3K27ac.bwa.GRCh38.20160310.bed.gz","FILE_TYPE":"CHIP_MACS2_BED","ANALYSIS_GROUP":"EMBL-EBI","TYPE":"Enriched regions","PATH":"http://ftp.ebi.ac.uk/pub/databases/blueprint/data/homo_sapiens/GRCh38/capillary_blood/T12C/T-cell_Acute_Lymphocytic_Leukemia/ChIP-Seq/NCMLS/S01PX4H1.ERX1305349.H3K27ac.bwa.GRCh38.20160310.bed.gz","PROTOCOL_DOC":"chip_seq_grch38","MD5":"8951580a5dc9fe4a99e43a7c660ed669"},{"FORMAT":"Text","SIZE":"538K","NAME":"S01PX4H1.ERX1305349.H3K27ac.bwa.GRCh38.20160310.xls.gz","FILE_TYPE":"CHIP_MACS2_BED","ANALYSIS_GROUP":"EMBL-EBI","TYPE":"Enriched regions","PATH":"http://ftp.ebi.ac.uk/pub/databases/blueprint/data/homo_sapiens/GRCh38/capillary_blood/T12C/T-cell_Acute_Lymphocytic_Leukemia/ChIP-Seq/NCMLS/S01PX4H1.ERX1305349.H3K27ac.bwa.GRCh38.20160310.xls.gz","PROTOCOL_DOC":"chip_seq_grch38","MD5":"151c6dda4b6f19f6b437dcbf9b9c60c8"}],"dataset_id":"EGAD00001002400","sample":{"SAMPLE_SOURCE":"capillary blood","SAMPLE_NAME":"T12C","sample_barcode":"S01PX4H1","attributes":{"DONOR_HEALTH_STATUS":["T-cell Acute Lymphocytic Leukemia"],"DONOR_AGE":["0 - 5"],"MOLECULE":["genomic DNA"],"DISEASE":["T-cell Acute Lymphocytic Leukemia"],"BIOMATERIAL_PROVIDER":["Necker's hospital"],"BIOMATERIAL_TYPE":["Primary Tissue"],"TISSUE_TYPE":["capillary blood"],"DISEASE_ONTOLOGY_URI":[{"url":"9","label":"C0023449"}],"SUBJECT_ID":["T12C"],"SAMPLE_ONTOLOGY_URI":[{"url":"7","label":"UBERON_0013757"}],"GENDER":["male"],"DONOR_ID":["T12C"],"DONOR_SEX":["Male"],"PASSAGE_IF_EXPANDED":["none"]},"SAMPLE_ID":"EGAN00001358214","SAMPLE_DESCRIPTION":"T-cell Acute Lymphocytic Leukemia"}}